Physician profile

Ignacio Sarmina

Urology · Lafayette, IN

NPI 1861435554

$1,403.27

in general payments reported to CMS, 2019-2025

18 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astellas Pharma US INC $653.15 2019-2021
Rochester Medical Corporation $219.90 2019-2021
Janssen Biotech, INC. $162.49 2019-2022
Neotract INC. $108.55 2020
Myovant Sciences INC. $27.62 2021
Ferring Pharmaceuticals INC. $25.98 2019
Pfizer INC. $25.84 2019-2020
Merck Sharp & Dohme LLC $23.52 2021
Laborie Medical Technologies Corp. $18.70 2021
Tolmar Pharmaceuticals, INC. $18.64 2020
Amgen INC. $18.26 2019
Becton, Dickinson and Company $17.44 2019
Blue Earth Diagnostics $16.55 2021
Coloplast Corp $15.31 2021
Endo Pharmaceuticals INC. $14.97 2019
Show all 18 companies
CompanyGeneral paymentsYearsTop products
Allergan, INC. $12.59 2019
Therapeuticsmd, INC. $12.50 2019
Abbvie INC. $11.26 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ignacio Sarmina

$1,403.27

in general payments reported 2019-2025

Years
2019-2022
Top company
Astellas Pharma US INC

https://glasscript.com/doctor/357067/ignacio-sarmina

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.